loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2000_376___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Syntacoll GmbH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Syntacoll GmbH Saal/Donau DE (1)

    filter

    01 Collagen (1)

    filter

    01 Germany (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Syntacoll GmbH Saal/Donau DE

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Germany
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Collagen

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2000-376 - Rev 03
      Valid
      TSE
      2020-10-16
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-376 - Rev 03 of Syntacoll Gmbh Saal/donau De

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-376 - Rev 03 of Syntacoll Gmbh Saal/donau De 1

      20

      Syntacoll Gmbh Saal/donau De, based in Germany, is a pharmaceutical company.

      One of their significant offerings is Collagen, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-376 - Rev 03

      This TSE Type CEP, issued on October 16, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Post Enquiry
      POST ENQUIRY